Click on add to cart to add all the sections in shopping cart
Click on the cart to proceed to payment
Click on Checkout to complete the final checkout
OTC Pharmaceuticals in Turkey industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Turkey otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters and bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2014 annual average exchange rates.
The Turkish OTC Pharmaceuticals market had total revenues of USD 1.3bn in 2014, representing a compound annual growth rate (CAGR) of 6.9% between 2010 and 2014.
The analgesics segment was the market's most lucrative in 2014, with total revenues of USD 348.3m, equivalent to 26% of the market's overall value.
Turkey's spending on healthcare was approximately 5.1% of GDP, way below the average OECD figure of 8.9% but represents a clear increase from 2.5% in 1990.
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Turkey
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Turkey
Leading company profiles reveal details of key otc pharmaceuticals market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Turkey otc pharmaceuticals market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Turkey economy
Reasons To Buy
What was the size of the Turkey otc pharmaceuticals market by value in 2014?
What will be the size of the Turkey otc pharmaceuticals market in 2019?
What factors are affecting the strength of competition in the Turkey otc pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in Turkey's otc pharmaceuticals market?
Single User License:
Report can be used by individual purchaser only
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Abdi Ibrahim Ilac Sanayi ve Ticaret A.S.; GlaxoSmithKline Plc; Nobel Ilac San ve Tic A.S.; Novartis AG
"Marketing Manager, Western Union Business Solutions"
"Sales Manager, Largest India Aesthetic Laser Manufacturer"
For Regular updates on our latest research reports